Home / News / Industry News / How to Choose the Right Flip Off Cap?

How to Choose the Right Flip Off Cap?

2026.06.26

Choosing the right flip off cap comes down to five core decisions: vial neck finish diameter, material and seal compatibility, regulatory compliance requirements, sterilization method, and color coding for product identification. Get these five factors right and the cap will perform reliably through filling, sealing, sterilization, storage, and end-user access. Get any one of them wrong and you face leakage, contamination risk, regulatory rejection, or patient safety issues. This guide covers each decision in practical detail so you can specify the correct cap confidently for any injectable, lyophilized, or liquid pharmaceutical product.

What a Flip Off Cap Is and Why the Choice Matters

A flip off cap is a combination aluminum-plastic closure used to seal pharmaceutical vials. It consists of an aluminum ferrule that crimps mechanically over the vial neck and rubber stopper, and a central plastic button — typically polypropylene — that the user flips off to expose the rubber septum for needle insertion. The plastic button provides tamper evidence and clean-surface access; the aluminum shell provides the structural seal and tamper-evident crimped retention.

This combination design is the global standard for injectable drug products, vaccine vials, lyophilized biologics, and multi-dose liquid formulations. According to the World Health Organization (WHO), over 8 billion vial closures are used globally each year in injectable drug manufacturing, with flip off aluminum-plastic caps representing the dominant closure format in both human and veterinary pharmaceutical applications. (Source: WHO Technical Report Series, No. 1025, Annex 2, 2021)

The consequences of an incorrect cap specification are significant: inadequate seal integrity allows microbial ingress; wrong diameter causes crimping failure or post-crimp movement; incompatible materials cause extractables that contaminate the drug product; non-compliant caps fail regulatory audits in major markets including the FDA, EMA, and NMPA.

Factor One: Vial Neck Finish Diameter

The most fundamental specification is the vial neck finish diameter. The flip off cap must match the vial neck precisely — the aluminum ferrule is crimped under the vial bead, and any mismatch in diameter causes either incomplete crimp engagement (leak risk) or over-crimping that distorts the ferrule and compromises the seal.

Standard Diameters and Their Applications

Ferrule Diameter Typical Vial Volume Range Common Application
13 mm 1 ml to 10 ml Single-dose injectables, vaccines, ophthalmic preparations
20 mm 5 ml to 100 ml Multi-dose vaccines, lyophilized biologics, antibiotics
28 mm 50 ml to 250 ml Large-volume injectables, veterinary formulations
32 mm 100 ml to 500 ml Bulk veterinary injectables, large-volume infusion preparations

Diameter specifications follow ISO 8362-6 for injection vials and ISO 8536 for infusion preparations. Always confirm the exact vial manufacturer's neck finish drawing before specifying cap diameter — nominal diameter and actual finish dimensions vary slightly between vial manufacturers and must be validated in combination. (Source: ISO 8362-6:2020, Injection Containers and Accessories — Aluminium Caps for Injection Vials)

Factor Two: Material Compatibility with the Drug Product

Flip off caps contact the drug product indirectly — through the rubber stopper that the aluminum ferrule retains and that the plastic button exposes. However, the materials of both the aluminum shell and the plastic button must still be evaluated for extractables and leachables that can migrate into the drug product under storage conditions.

Aluminum Ferrule Material Standards

The aluminum alloy used in pharmaceutical flip off caps must comply with the relevant pharmacopeial standards for heavy metal content and surface treatment. The most widely specified standard is USP Class VI for primary packaging materials in contact with injectable drug products, combined with compliance to:

  • European Pharmacopoeia (Ph. Eur.) Chapter 3.2.5 — Containers for Preparations Not for Parenteral Use (aluminum closures)
  • United States Pharmacopeia (USP) Chapter 660 — Containers — Glass (associated closure requirements)
  • Chinese Pharmacopoeia (ChP) Volume IV — Standards for Pharmaceutical Packaging Materials

The aluminum surface is typically coated or lacquered to prevent oxidation and contamination from direct handling. Specify lacquered or PVC-free coated ferrules for markets requiring restricted substance compliance, particularly the EU where PVC-containing pharmaceutical packaging requires specific justification under EMA guidance. (Source: EMA Guideline on Plastic Immediate Packaging Materials, EMEA/CHMP/QWP/4359/03 Rev 1)

Plastic Button (Polypropylene) Specifications

The flip-off plastic button is injection-molded from pharmaceutical-grade polypropylene (PP). Requirements include:

  • Pharmaceutical-grade resin: PP compliant with Ph. Eur. 3.1.6 (Polypropylene for Containers and Closures) or equivalent USP specification
  • No recycled content: Virgin resin only in primary pharmaceutical packaging to ensure consistent extractable profile
  • Colorant compliance: Any pigment used for color coding must be inorganic or meet specific migration limits under EU Regulation 10/2011 on plastic materials in contact with food (applied by analogy to pharmaceutical packaging)

Factor Three: Seal Integrity Requirements

A flip off cap must maintain container closure integrity (CCI) through filling, sterilization, storage, and distribution — including temperature cycling from cold chain storage (-20 to +8 degrees Celsius for some biologics) through to ambient distribution temperatures of up to 40 degrees Celsius. The key seal integrity parameters to specify and validate are:

Crimp Height and Residual Seal Force

After crimping, the ferrule applies a defined compressive force to the rubber stopper — the Residual Seal Force (RSF). The correct RSF window ensures the stopper is compressed sufficiently to maintain a gas-tight seal without over-compressing to the point of permanent deformation that would weaken the seal over time. According to USP Chapter 1207 on Container Closure Integrity, RSF values for standard 20 mm vials typically fall between 30 and 70 Newtons for acceptable CCI across the storage life of most injectable products. (Source: USP Chapter 1207, Package Integrity Evaluation — Sterile Products)

Aluminum Hardness and Temper Grade

The aluminum alloy temper grade determines how the ferrule deforms during crimping. The standard for pharmaceutical flip off caps is aluminum alloy 8011 or 1100 series at H14 or H16 temper, which provides the combination of formability during crimping and spring-back resistance needed to maintain the crimp geometry under temperature cycling. Softer tempers crimp cleanly but may relax under cold storage; harder tempers require higher crimping force and risk ferrule cracking. (Source: ASTM B209, Standard Specification for Aluminum and Aluminum-Alloy Sheet and Plate)

Factor Four: Sterilization Compatibility

The sterilization method used in your filling process determines critical cap specifications. Three main sterilization routes apply to flip off caps in pharmaceutical manufacturing:

Sterilization Method Cap Material Requirement Temperature Limit Common Use Case
Gamma irradiation Radiation-stable PP grade; aluminum unaffected No temperature concern Pre-sterilized caps for aseptic filling lines
Ethylene oxide (EtO) EtO-permeable packaging required; low residual EtO spec Under 60 degrees Celsius Heat-sensitive drug products
Steam autoclave (terminal sterilization) PP must withstand 121 degrees Celsius, 15 minutes 121 to 134 degrees Celsius Terminally sterilized aqueous injectables

For gamma irradiation, confirm that the PP resin grade is stabilized against radiation-induced oxidation — standard PP without antioxidant stabilization yellows and becomes brittle at doses above 15 kGy, which falls within the standard pharmaceutical sterilization range of 25 to 50 kGy. Request a certificate of irradiation compatibility from the cap manufacturer specifying the maximum dose and color stability. (Source: ISO 11137-1:2006, Sterilization of Health Care Products — Radiation)

Factor Five: Color Coding and Identification

Color coding of flip off cap plastic buttons is a well-established pharmaceutical practice for rapid visual identification of product strength, formulation type, or pack size at both the dispensing and administration stages. Selecting the correct color system requires coordination across several requirements:

  • Internal SOP consistency: Match the color allocation to your existing product identification system across all vial sizes and formulations to avoid cross-contamination risk at dispensing
  • Market regulatory requirements: Some national medicines authorities publish guidance or mandatory color coding requirements for specific drug classes. Confirm the applicable requirements in each target market before freezing the color specification
  • Color stability through sterilization: Confirm that the specified pigment maintains its color identity through the chosen sterilization process — gamma irradiation in particular can cause visible color shift in some pigment systems, making post-sterilization visual inspection unreliable
  • Minimum order quantities per color: If multiple colors are required across product variants, confirm minimum order quantities and lead times for each color to avoid supply chain constraints during product launch

The standard color range for pharmaceutical flip off caps includes red, blue, green, yellow, orange, purple, grey, and white, with custom colors available from established manufacturers for product differentiation requirements.

Regulatory Compliance Requirements by Market

Regulatory compliance of the flip off cap is a non-negotiable prerequisite in every major pharmaceutical market. The required documentation and testing vary by market:

Market Key Standard or Regulation Required Documentation
USA (FDA) USP 660, USP 1207, 21 CFR 211.94 Drug Master File (DMF) for packaging, CCI validation data
European Union (EMA) Ph. Eur. 3.2.5, EMA packaging guidelines Certificate of Conformity, extractables/leachables data
China (NMPA) ChP Volume IV, YBB standards for pharmaceutical packaging Registration certificate for packaging material (YBB registration)
WHO prequalification WHO Technical Report Series Annexes Packaging qualification data, supplier audit certificates
Japan (PMDA) JP (Japanese Pharmacopoeia) packaging standards Conformance certificate and material test reports

A reliable cap supplier should provide a Drug Master File (DMF) or Letter of Access to an existing DMF for submissions to FDA-regulated markets, and a Certificate of Conformity to Ph. Eur. standards for EMA markets. Suppliers who cannot provide these documents present a significant regulatory risk regardless of their manufacturing capability.

Choosing a Reliable Flip Off Cap Supplier

The specifications above only deliver value if the manufacturing processes behind them are consistent. When evaluating a flip off cap supplier, assess these operational factors alongside product specifications:

  • GMP certification: Pharmaceutical packaging manufacturing under ISO 15378 (Primary Packaging Materials for Medicinal Products) or equivalent GMP standard is the minimum acceptable quality system for flip off cap suppliers
  • Manufacturing scale and capacity: Confirm that the supplier's annual capacity comfortably exceeds your projected volume to ensure supply security during demand peaks or market launches
  • Cleanroom production environment: Flip off caps for aseptic filling applications must be produced in classified cleanroom conditions (ISO Class 7 or better for final assembly and packaging) to meet the particulate and bioburden specifications required before sterilization
  • In-process quality control: Confirm that 100% dimensional inspection and statistical process control (SPC) are applied to critical dimensions including ferrule diameter, height, and plastic button integrity, with AQL sampling per ISO 2859-1 for visual defects
  • Supply chain traceability: Full material traceability from aluminum coil and PP resin to finished cap batch is required for regulatory compliance and root cause investigation of any field quality event

Jiangsu Changjiang Lids Co., Ltd. has specialized in pharmaceutical packaging manufacturing since 2000, with over two decades of production experience in flip off caps and aluminum-plastic closures. Based in Yangzhong, Jiangsu Province — the center of the Yangtze River Delta industrial corridor — the company operates across a 20,000 square meter facility with a registered capital of 45.68 million yuan. Their aluminum-plastic flip off cap range covers standard diameters from 13 mm to 32 mm in multiple colors and material configurations, supported by the regulatory documentation and quality certifications required for major global pharmaceutical markets.

Flip Off Cap Selection Checklist

Use this checklist when specifying a flip off cap for a new product or supplier qualification:

Selection Factor Key Question to Answer Typical Options
Ferrule diameter What is the vial neck finish diameter per the vial drawing? 13 mm, 20 mm, 28 mm, 32 mm
Aluminum alloy and temper Does the alloy meet Ph. Eur. and USP specifications? Alloy 8011 or 1100, H14 or H16 temper
Plastic button material Is the PP grade pharmaceutical-grade, virgin resin? PP compliant with Ph. Eur. 3.1.6
Surface treatment Is the ferrule lacquered or PVC-free coated? Lacquered, PVC-free coated, plain
Sterilization compatibility What sterilization method will be used? Gamma, EtO, steam autoclave
Color What color coding is required for product identification? Red, blue, green, yellow, orange, purple, grey, white, custom
Regulatory documentation Which markets require DMF, CoC, or YBB registration? FDA DMF, Ph. Eur. CoC, NMPA YBB, WHO prequalification
Supplier GMP status Is the supplier certified to ISO 15378 or equivalent? ISO 15378, GMP audit certificate

The bottom line: selecting the right flip off cap is a structured specification process, not a commodity purchasing decision. Matching diameter, material, sterilization compatibility, and regulatory documentation to your specific vial, drug product, and target market eliminates the most common causes of closure failure, contamination risk, and regulatory rejection before they can affect your product quality or launch timeline.